Vanda Pharmaceuticals Inc. (VNDA) Earnings Call Analysis
NASDAQ · Healthcare · Biotechnology
Next earnings call: 2026-08-05
(Q2 2026)
— full calendar
Earnings Reports
-
Vanda Pharmaceuticals (VNDA) Q4 2025: FNAPT Prescriptions Jump 36% as Psychiatry Franchise Expands
June 15, 2026
-
Vanda Pharmaceuticals (VNDA) Q1 2026: FNAP Prescriptions Jump 32% as Nereus Launches DTC Model
May 07, 2026
-
Vanda (VNDA) Q3 2025: FNAP Prescriptions Up 35% as Bipolar Indication Drives Commercial Surge
October 30, 2025
-
Vanda Pharmaceuticals (VNDA) Q2 2025: FNAPT Prescriptions Surge 24% as Sales Force Expansion Accelerates
July 31, 2025
-
Vanda Pharmaceuticals (VNDA) Q1 2025: FNAP Prescriptions Jump 14%, Fueling Psychiatry Franchise Expansion
July 04, 2025